Subthalamic deep brain stimulation (DBS): clinical efficacy, safety and cost compared to medical therapy for the treatment of Parkinson's Disease
Pan I, Dendukuri N, McGregor M
Record ID 32010000171
English
Authors' recommendations:
There is clear evidence that Deep Brain Stimulation improves motor function and sustains quality‐of‐life in patients with medically‐resistant disease for a period of at least 5 years. It is important that this intervention be performed by a skilled and experienced centre such as the MNH where expertise and experience have already been accumulated. Optimalselection and follow‐up of patients is necessary to minimize the risk of adverse outcomes. There is an increasing waiting list in Quebec. To increase the turnover at the MNH by 15patients per year would require $246,000 per year for equipment, or a total of approximately $411,672 (excluding costs of treating procedure related complications) per year during the first 5 years. Through reduction in medication costs there would be a significant saving from the point of view of the provincial health authority, but this would not affect the MUHC.
Details
Project Status:
Completed
URL for project:
http://www.mcgill.ca/files/tau/DBS_REPORT.pdf
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Costs and Cost Analysis
- Parkinson Disease
Contact
Organisation Name:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
Contact Address:
Technology Assessment Unit of the MUHC, 536-5100 Boul. Maisonneuve O, Montreal, H4A 3T2
Contact Name:
eva.suarthana@mcgill.ca
Contact Email:
nisha.almeida@muhc.mcgill.ca
Copyright:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.